To hear about similar clinical trials, please enter your email below

Trial Title: Clinical Trial Using Bipolar Technology for Transurethral Resection of Bladder Tumor

NCT ID: NCT01581723

Condition: Urinary Bladder Tumor

Conditions: Official terms:
Urinary Bladder Neoplasms

Conditions: Keywords:
urinary bladder tumor
monopolar TURBT
bipolar TURBT

Study type: Interventional

Study phase: Phase 3

Overall status: Unknown status

Study design:

Allocation: Randomized

Intervention model: Parallel Assignment

Primary purpose: Treatment

Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

Intervention:

Intervention type: Device
Intervention name: Monopolar diathermy
Description: monopolar diathermy
Arm group label: Monopolar TUR

Other name: Olympus Monopolar HF-resection Electrode

Other name: Model: A22205A

Intervention type: Device
Intervention name: Bipolar diathermy
Description: bipolar diathermy
Arm group label: Biploar TUR

Other name: Olympus TURis Bipolar HF-resection electrode

Other name: Model: WA22306D

Summary: Bladder cancer is a common urological malignant disease. Patients with bladder cancer will first be managed with transurethral resection (TUR) of bladder tumor. For many years, monopolar transurethral resection of bladder tumor (TURP) has been the gold standard for treatment. However, complications including bleeding, bladder perforation and inadequate sampling of deep tumor biopsy remain the major concerns. Recently published papers suggested that the newer bipolar TUR technology has similar surgical outcomes but less complications comparing with monopolar TUR. In this study, investigators will investigate the benefit of new technology as compared with conventional monopolar resection on tumor clearance, complication and recurrence rates.

Detailed description: Transurethral resection (TUR) of bladder tumor is one of commonest procedures in urology practice. It is the surgery of choice for staging and treating non-muscle invasive bladder cancer. Short lengths of hospital stay, simple and safe are the main advantages of the surgery. Conventional TUR is performed with monopolar diathermy, which commonly elicits obturator reflexes in lateral-located tumor. However, it is not without complication. Bleeding and bladder perforation with or without obturator reflex are the most significant complications after TUR of bladder tumor. The charring effect of monopolar is also a concern as the diagnosis of muscle invasion by tumor is determined by the integrity of tumor base biopsy. Mariappan et al. reported that as high as 33% of the specimen had no detrusor muscle present for assessment. The absent of muscle not only affect the staging procedure but also associated with higher cancer recurrence rate. Bipolar resection has been widely used in transurethral resection of prostate (TURP). As compared with the traditional monopolar technology, the electric current passes through the instrument sheath. The advantage of bipolar technology includes less obturator reflex, good hemostasis and early recovery. Study has showed that the cautery artifact is more severe on monopolar resection as compared with bipolar in prostate tissues. Due to the clean and precise cutting, there will be less charring on the specimen and thermal injury to peripheral tissues. Applying to bladder tumor resection, this will improve the staging accuracy with better determination of the depth of invasion. Furthermore, with the use of saline instead of glycine as irrigation fluid, risk of TUR syndrome is minimized. There is no randomized trial on the benefit of using bipolar instrument on TUR bladder cancer. In this study, investigator will investigate the role of bipolar technology in TUR bladder cancer as compared with traditional monopolar resection.

Criteria for eligibility:
Criteria:
Inclusion Criteria: - Adult male or female patients (age ≥ 18) - Patients who have diagnosed with bladder cancer (either primary or recurrent) by cystoscopy Exclusion Criteria: - Patients who are scheduled for second TUR within 6 weeks after the previous TUR

Gender: All

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Prince of Wales Hospital

Address:
City: Shatin
Country: Hong Kong

Status: Recruiting

Investigator:
Last name: Eddie SY Chan, MD
Email: Principal Investigator

Investigator:
Last name: Chi Fai Ng, MD
Email: Sub-Investigator

Investigator:
Last name: Simon SM Hou, MBBS
Email: Sub-Investigator

Facility:
Name: North District Hospital

Address:
City: Sheung Shui
Country: Hong Kong

Status: Not yet recruiting

Investigator:
Last name: Ho Yuen Cheung, MBChB
Email: Sub-Investigator

Start date: May 2012

Completion date: September 2015

Lead sponsor:
Agency: Chinese University of Hong Kong
Agency class: Other

Source: Chinese University of Hong Kong

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT01581723

Login to your account

Did you forget your password?